Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Pairs With Metabometrix in Effort to Marry Metabolic and Gene Expression Data

Premium

Gene Logic has taken an equity investment of an undisclosed amount in Metabometrix, a London-based startup, as part of a research collaboration to link metabolic and gene expression data.

The investment is an unusual move for Gene Logic. “We are very selective in the companies with whom we make that additional relationship, and we identified Metabometrix as a worthy entity to take a small equity position in,” said Bob Burrows, director of corporate communications for the Gaithersburg, Md.-based company. “Based on the still-unproven technology that they have, we see potential value in it in terms of an equity investment, but more importantly as a source of generating a wholly complementary dataset to our gene expression information.”

Metabometrix uses high-field nuclear magnetic resonance spectroscopy and chemometric methods to generate, classify, and interpret high-density metabolic data. Metabometrix will apply its technology to samples provided by Gene Logic and other sources.

The data derived from the research collaboration is expected to complement the ToxExpress module of Gene Logic’s GeneExpress database, which contains information on human and experimental animal tissue samples treated with known toxic compounds for predictive toxicology assessment. Burrow said the specifics of the data generation process and the eventual form it would take are still being determined. While he confirmed the collaboration would result in new content for GeneExpress, it is still unclear whether it will comprise a new module or exist within ToxExpress.

— BT

Filed under

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.